ストックスクリーナーアプリを入手
133.26
2.25%
-3.07
前日終値:
$136.33
開ける：
$135.65
24時間の取引高:
1.56M
Relative Volume:
0.70
時価総額：
$28.76B
収益：
$606.42M
当期純損益:
$-1.28B
株価収益率:
-20.81
EPS:
-6.403
ネットキャッシュフロー:
$-997.58M
1週間 パフォーマンス:
-1.41%
1か月 パフォーマンス:
-19.17%
6か月 パフォーマンス:
-29.72%
1年 パフォーマンス:
+83.45%
1日の値動き範囲:
$132.39
$137.62
1週間の範囲:
$132.39
$139.54
52週間の値動き範囲:
$63.81
$212.75
Insmed Inc Stock (INSM) Company Profile
Compare INSM vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
133.26 | 28.76B | 606.42M | -1.28B | -997.58M | -6.403 |
VRTX
Vertex Pharmaceuticals Inc
|
423.92 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
701.42 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
783.50 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.11 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
293.86 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | 開始されました | Raymond James | Outperform |
| 2026-03-30 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2026-03-16 | 再開されました | Jefferies | Buy |
| 2026-01-28 | 開始されました | Barclays | Overweight |
| 2026-01-23 | 開始されました | Roth Capital | Buy |
| 2025-12-19 | 再開されました | Truist | Buy |
| 2025-12-04 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-10-28 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-10-20 | 開始されました | Wells Fargo | Overweight |
| 2025-08-20 | 開始されました | William Blair | Outperform |
| 2025-08-13 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 開始されました | Jefferies | Buy |
| 2025-02-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-04-23 | 開始されました | Truist | Buy |
| 2024-02-15 | 開始されました | Wolfe Research | Outperform |
| 2023-12-08 | 開始されました | Wells Fargo | Overweight |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-07-26 | 開始されました | Guggenheim | Buy |
| 2022-12-09 | 開始されました | Mizuho | Buy |
| 2022-12-07 | 開始されました | Barclays | Overweight |
| 2022-11-18 | 開始されました | BofA Securities | Buy |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2021-12-06 | 開始されました | JP Morgan | Overweight |
| 2021-10-19 | 再開されました | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-12-17 | 開始されました | Berenberg | Buy |
| 2020-10-12 | 再開されました | Stifel | Buy |
| 2019-09-03 | 開始されました | Goldman | Buy |
| 2019-04-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-02-15 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | アップグレード | Goldman | Neutral → Buy |
| 2019-01-02 | 開始されました | Canaccord Genuity | Buy |
| 2018-08-06 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 開始されました | Goldman | Neutral |
| 2018-04-23 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 開始されました | Morgan Stanley | Overweight |
| 2018-01-18 | 開始されました | Credit Suisse | Neutral |
| 2017-09-05 | 繰り返されました | Evercore ISI | Outperform |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-07-11 | 開始されました | Robert W. Baird | Outperform |
| 2016-03-15 | 開始されました | Stifel | Buy |
| 2015-11-09 | ダウングレード | UBS | Buy → Neutral |
| 2015-10-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-06-09 | 開始されました | Citigroup | Neutral |
| 2014-03-26 | 繰り返されました | HC Wainwright | Buy |
すべてを表示
Insmed Inc (INSM) 最新ニュース
Vanguard’s Larger Passive Stake Puts Insmed’s Volatile Story In Focus - Yahoo Finance
Earnings Preview: Insmed to Report Financial Results Pre-market on May 07 - Moomoo
Jennison Associates LLC Decreases Position in Insmed, Inc. $INSM - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Purchases New Position in Insmed, Inc. $INSM - MarketBeat
Insmed executives line up two healthcare investor conference talks in May - Stock Titan
Vanguard (NASDAQ: INSM) reports 11.5M Insmed shares, 5.34% stake - Stock Titan
Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Insmed (INSM) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Insmed to Present at May 2026 Investor Conferences - PR Newswire
Book value per share of Insmed Incorporated – LSE:0JAV - TradingView
Insmed (INSM) soars 5.5%: Is further upside left in the stock? - MSN
Insmed drops skin disorder candidate after mid-stage trial setback - MSN
Vanguard Group Inc. Has $3.67 Billion Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: United Therapeutics (UTHR), Insmed (INSM) and MannKind (MNKD) - The Globe and Mail
Pictet Asset Management Holding SA Sells 181,864 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed Stock Hits Day Low of $134.72 Amid Price Pressure - Markets Mojo
Non-Cystic Fibrosis Bronchiectasis Pipeline Set for Significant Expansion by 2026 with 12+ Therapies and Robust Clinical Progress from Haisco Pharmaceutical, CSL Behring, Insmed, Zambon | DelveInsight - Barchart
Insmed ends Brinsupri development in skin disease post study failure - MSN
Insmed, Inc. $INSM Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Insmed (INSM) Slips 6% as Investors Continue to Digest Failed HS Trial and Reposition Ahead of Upcoming Earnings - Moomoo
Insmed (INSM) slips 6% as investors continue to digest failed HS trial and reposition ahead of upcoming earnings - Quiver Quantitative
Insmed (NASDAQ:INSM) Trading Down 5.9%What's Next? - MarketBeat
The ESG Growth Portfolio's Insmed Inc(INSM) Holding History - GuruFocus
Insmed Incorporated (INSM) PT Lifted to $230 as Guggenheim Updates Biotech Earnings Models - Yahoo Finance
How The Insmed (INSM) Investment Story Is Shifting On Brinsupri And ENCORE Developments - Yahoo Finance
KLP Kapitalforvaltning AS Has $12.88 Million Stock Position in Insmed, Inc. $INSM - MarketBeat
INSM|Insmed Inc|Price:135.170|Chg%:-8.66 - TradingKey
The 'worst-case scenario' — why Insmed just reversed after a 181% six-month sprint - MSN
Insmed’s TPIP Extension Study Completion: What Long-Term PH-ILD Data Could Mean for INSM Investors - TipRanks
Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 - Financial Times
INSMED EV-to-OCF: -30.50 | Fairly Valued - GuruFocus
Zurcher Kantonalbank Zurich Cantonalbank Raises Holdings in Insmed, Inc. $INSM - MarketBeat
M&T Bank Corp Grows Stock Position in Insmed, Inc. $INSM - MarketBeat
Asset Management One Co. Ltd. Purchases Shares of 80,887 Insmed, Inc. $INSM - MarketBeat
Insmed Inc stock (US4576693075): Is the rare disease pipeline strong enough to unlock new upside? - AD HOC NEWS
Insmed Incorporated (INSM) Stock Analysis: Potential 47% Upside With Strong Buy Ratings - DirectorsTalk Interviews
Mirae Asset Global Investments Co. Ltd. Acquires 69,410 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed Stock Hits Day Low of $135.73 Amid Price Pressure - Markets Mojo
GF Fund Management CO. LTD. Grows Stake in Insmed, Inc. $INSM - MarketBeat
KBC Group NV Buys 24,396 Shares of Insmed, Inc. $INSM - MarketBeat
INSM Reiterates by Roth Capital -- Price Target Maintained at $2 - GuruFocus
Insmed chair and CEO William Lewis sells $1.54m in stock - Investing.com
Insider Selling: Insmed (NASDAQ:INSM) CEO Sells 10,699 Shares of Stock - MarketBeat
INSMED (INSM) CEO exercises options and sells 10,699 shares under 10b5-1 plan - Stock Titan
Roth Mkm Reaffirms "Buy" Rating for Insmed (NASDAQ:INSM) - MarketBeat
Roth MKM Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $212 - Moomoo
William Lewis lists INSM share sales (NASDAQ: INSM) in Form 144 filing - Stock Titan
Guggenheim raises Insmed stock price target to $230 on Arikayce By Investing.com - Investing.com Canada
Guggenheim Maintains Insmed(INSM.US) With Buy Rating, Raises Target Price to $230 - Moomoo
Insmed, Inc. (NASDAQ:INSM) Short Interest Update - MarketBeat
Insmed Inc stock (US4576693075): Is brensocatib approval the real test for rare disease growth? - AD HOC NEWS
Insmed Inc (INSM) 財務データ
収益
当期純利益
現金流量
EPS
Insmed Inc (INSM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Lewis William | Chair and CEO |
Apr 16 '26 |
Sale |
143.97 |
10,699 |
1,540,332 |
301,185 |
3.22%
大文字化:
|
ボリューム (24 時間):